UniProtKB/Swiss-Prot Q9NQ40 : Variant p.Arg132Trp
Solute carrier family 52, riboflavin transporter, member 3
Gene: SLC52A3
Feedback ?
Variant information
Variant position:
132
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Arginine (R) to Tryptophan (W) at position 132 (R132W, p.Arg132Trp).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from large size and basic (R) to large size and aromatic (W)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In BVVLS1; loss of localization to cell membrane; loss of riboflavin transport; does not affect protein abundance.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
132
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
469
The length of the canonical sequence.
Location on the sequence:
TFFLALVDCTSSVTFLPFMS
R LPTYYLTTFFVGEGLSGLLP
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TFFLALVDCTSSVTFLPFMSR LPTYYLTTFFVGEGLSGLLP
Mouse TFFLALVDCTSSVTFLPFMSQ LPTYYLTTFFIGEGLSGLLP
Rat TFFLALVDCTSSVTFLPFMSQ LPTYYLTTFFIGEGLSGLLP
Bovine TFFLALVDCTSSVTFLPFMSR LPTYYLTTFFVGEGLSGLLP
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 469
Solute carrier family 52, riboflavin transporter, member 3
Topological domain
119 – 137
Cytoplasmic
Literature citations
Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54.
Green P.; Wiseman M.; Crow Y.J.; Houlden H.; Riphagen S.; Lin J.P.; Raymond F.L.; Childs A.M.; Sheridan E.; Edwards S.; Josifova D.J.;
Am. J. Hum. Genet. 86:485-489(2010)
Cited for: VARIANTS BVVLS1 LYS-36; TRP-132; LEU-224; ALA-413 AND LEU-457; VARIANT MET-350;
Effect of clinical mutations on functionality of the human riboflavin transporter-2 (hRFT-2).
Nabokina S.M.; Subramanian V.S.; Said H.M.;
Mol. Genet. Metab. 105:652-657(2012)
Cited for: CHARACTERIZATION OF VARIANTS BVVLS1 ARG-17; THR-28; LYS-36; LYS-71 AND TRP-132; CHARACTERIZATION OF VARIANT MET-350; FUNCTION; TRANSPORTER ACTIVITY; SUBCELLULAR LOCATION;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.